Wayne Kuzner | Authors


PSMA-Directed Therapies and Diagnostics Expand Their Scope in Prostate Cancer

May 14, 2021

With the emergence of therapies that target PSMA, a cell surface transmembrane protein that is overexpressed in most prostate cancer cells, particularly in castration-resistant disease, the ability to detect and treat the disease has been transformed.

Continuous Low-Dose Ribociclib Active in Advanced Breast Cancer Causes Less Neutropenia

December 13, 2016

Continuous low-dose ribociclib shows preliminary activity, and has an acceptable safety profile as an alternative to intermittent ribociclib dosing when combined with fulvestrant in the treatment of postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer.